Summary Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) and features dormant and discontinued projects.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope - The report provides a snapshot of the Global Therapeutic Landscape of Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal). - The report reviews pipeline therapeutics for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. - The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. - The report reviews key players involved in the development of Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) therapeutics and enlists all their major and minor projects. - The report assesses Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. - The report summarizes all the dormant and discontinued pipeline projects. - The report reviews latest news related to pipeline therapeutics for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal).
Reasons to Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Identify and understand important and diverse types of therapeutics under development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal). - Identify potential new clients or partners in the target demographic. - Develop strategic initiatives by understanding the focus areas of leading companies. - Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it’s most promising pipeline therapeutics. - Devise corrective measures for pipeline projects by understanding Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Our reports have been used by over 10K customers, including:
513 pages •
By Global Industry Analysts
• Apr 2021
- The global market for Contrast Media is projected to reach US$5.3 billion by 2025, driven by the growing number of imaging procedures such as X-Rays, MRI, CT, and Ultrasound supported by the prevalence of chronic diseases among the growing global population and the ensuing diagnostic burden and demand for imaging...
192 pages •
By Global Industry Analysts
• Apr 2021
- Global Chronic Kidney Disease (CKD) Drugs Market to Reach $15.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Chronic Kidney Disease (CKD) Drugs estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 1.9% over...
KEY FINDINGS The global cleanroom consumables market is set to project a CAGR of 9.17% during the forecast period, 2021-2028. The growing need for quality products in the manufacturing industries, strict cleanroom regulations and standards, and thriving healthcare & biotechnology industries, drive market growth. MARKET...
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations...
Report Scope The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the...
120 pages •
By Infiniti Research Limited
• May 2021
Global Snoring Control Devices Market 2021-2025 The analyst has been monitoring the snoring control devices market and it is poised to grow by $ 323.25 million during 2021-2025, progressing at a CAGR of over 5% during the forecast period. Our report on snoring control devices market provides a holistic analysis, market...
175 pages •
By The Business Research Company
• May 2021
Major players in the wearable injectors market are Amgen, Becton, Dickinson and Co., Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, West Pharmaceutical Services,and Sensile Medical AG. The global wearable injectors market is expected to grow from $5.145 billion in 2020 to $5.709 billion...
Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 Summary Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Anemia of Chronic Disease pipeline landscape. The report provides comprehensive information...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.